Literature DB >> 3015903

Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains.

J M Short, A Wynshaw-Boris, H P Short, R W Hanson.   

Abstract

Hormonal regulatory elements within the phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) (PEPCK) promoter region were mapped using a series of 5' deletions linked to the amino-3'-glycosyl phosphotransferase structural gene. These deletion mutants were stably transfected into the genome of FTO-2B hepatoma cells. A 47-base pair region of the PEPCK promoter was identified which was essential for stimulation by dibutyryl cAMP. A 12-base pair core sequence (CTTACGTCAGAG) within this region shows significant homology with sequences in four other cAMP-regulated genes. There are two glucocorticoid regulatory elements within the promoter, as well as an inhibitory element which depresses the level of basal gene transcription. The deletion of this inhibitory sequence prevents the induction of the chimeric gene by dexamethasone. The existence of the hormone regulatory domains within the PEPCK promoter was confirmed by attaching these elements upstream of the heterologous Herpes simplex virus thymidine kinase structural gene, containing its own promoter.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015903

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice.

Authors:  M K Short; D E Clouthier; I M Schaefer; R E Hammer; M A Magnuson; E G Beale
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  Induction of mRNA for phosphoenolpyruvate carboxykinase (GTP) by dexamethasone in cultured rat hepatocytes requires on-going protein synthesis.

Authors:  V L Nebes; S M Morris
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

4.  Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements.

Authors:  A M Delegeane; L H Ferland; P L Mellon
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

5.  trans-acting factors interact with a cyclic AMP response element to modulate expression of the human gonadotropin alpha gene.

Authors:  J L Jameson; P J Deutsch; G D Gallagher; R C Jaffe; J F Habener
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

Review 6.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene transcription.

Authors:  J Liu; R W Hanson
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

7.  Induction of a cyclic AMP-responsive gene in living cells requires the nuclear factor CREB.

Authors:  J L Meinkoth; M R Montminy; J S Fink; J R Feramisco
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter.

Authors:  L A Berkowitz; K T Riabowol; M Z Gilman
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  Small molecules capable of activating DNA methylation-repressed genes targeted by the p38 mitogen-activated protein kinase pathway.

Authors:  Xiang Li; Erchang Shang; Qiang Dong; Yingfeng Li; Jing Zhang; Shaohua Xu; Zuodong Zhao; Wei Shao; Cong Lv; Yong Zheng; Hailin Wang; Xiaoguang Lei; Bing Zhu; Zhuqiang Zhang
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

10.  Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.

Authors:  A Valera; J E Rodriguez-Gil; F Bosch
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.